The trial targets NIHs for hiding $ 9.7 million in transgender therapy research

This story discusses suicide. If you or someone you know, you have suicide thoughts, please contact suicide & Crifeline at 988 or 1-800-273-Talk (8255).

EXCLUSIVE: A high -level conservative custody pursues the federal bureaucracy on health care alleging that they are results of scenario of a study launched under the Obama administration on the effects of pharmaceuticals of transgender therapy on young people.

The president of the supervisory project, Mike Howell, told Fox News Digital in an interview on Wednesday that the administration of puberty blockers and other drugs emerging from adolescents is akin to “Modern experiences of Tuskegee” and that the National Institutes of Health and the study project should not be authorized to keep its secret results.

In 2014, NIH granted a subsidy to children’s hospitals that led to a study led by a Los Angeles pediatrician to discern the long -term effects of puberty blockers on pediatric transgender people, said Howll, citing the trial of his organization.

In 2024, the representative Lisa McClain, R-Mich., written by Biden The NIH wondering why the “principal researcher” Dr. Johanna Olson-Kennedy was “retained the publication” of the results of the $ 9.7 million study.

The legal group continues the FDA on the files of puberty blockers, citing the concealment of the Biden era

“In the light of the reluctance of the NIH concessionaire to publish the conclusions of the research project, we ask you to provide documents and information to help the committee surveillance on this issue,” McClain wrote, citing his role as president of a sub-comity of supervision of the house.

A year later, the Howell group asked for the files through a public request in July and continued this week, saying that the officials ignored them.

McClain, in his letter, and Howell, in his interview, have raised concerns concerning Olson-Kennedy’s remarks on criticism that potentially armed the results of the study funded by NIH.

“The NIH is responsible for supervising its extramural research projects to ensure that sustained researchers practice transparency, illustrate scientific integrity and are appropriate guards of taxpayers’ funds,” McClain wrote to Nih Biden.

Howell said he wanted the NIH under the Trump administration, to make public results, citing disturbing clues of Olson-Kennedy in a New York Times article This quoted him saying that a quarter of the participants reported a certain type of depression.

The Federal Court rejects the challenge of the Oklahoma law prohibiting gender transition treatment for minors

“In the light of the recent wave of violent extremism and domestic terrorism inspired by transgender ideology, including some of the shootings in schools and churches and, more recently, Charlie Kirk, the surveillance project and I want to know what the government knows about the psychological conditions of this new and coveted population of transgender children who are now developing in adults.”

“It seems to me, in the light of recent disclosure, in particular the America First Legal c. FDA (follows) that the government was well aware that these types of therapies, surgeries and cultural celebration and the praise of this class of people were dangerous and led to an increase in suicide rates, depression and other psychological conditions which, too often, are manifested in violent trends.”

In 2024, America First Legal – founded by Trump’s confidant, Stephen Miller, continued for the publication of all FDA files on outdoor AMM uses for puberty blockers and “cross -sex hormones”.

Howell said there was a public interest in the publication of the study, because it can “trace” why or if the government has been aware of the “massive and growing problem” but refused to make known for “politically correct reasons”.

Democratic states continue the Trump administrator at the end of sex change surgeries for minors

The demonstrators for and against medical procedures for transgender minors demonstrate outside the Supreme Court on December 4, 2024 in Washington. (AP photo / Jose Luis Magana, file)

While the NIH refused to comment Fox News Digital citing in progress disputes, the HHS secretary, Robert F. Kennedy Jr., was very critical of the types of drugs that are also concerned with the surveillance project.

Kennedy called puberty blockers for “castration drugs” minors and suggested that young people cannot be considered as sufficiently premonitory to make such medical decisions that change their life.

“Minors cannot drive, vote, join the army, get a tattoo, smoking or drinking, because we know that children do not fully understand the consequences of decisions with lifetime ramifications,” he wrote on social networks.

“The more I learn, the more I have troubled the idea of ​​giving young puberty blockers,” Kennedy said in May 2024.

As secretary, Kennedy urged doctors to reconsider The daily caller in May.

“HHS expects you to quickly do the necessary updates to your processing protocols and training for care for children and adolescents with gender dysphoria to protect them from these harmful interventions,” he read.

Neal Cornett, a senior lawyer in the case, told Fox News Digital that he would also like to see internal NIH reports on the physiological effects of related and supprrelin related drugs.

“Imagine that you are 14 years old – you take a kind of puberty blocker – you are fundamentally slowed down, your bones do not grow, you have osteoporosis at the age of 15 … This will make you a psychological number,” said Cornett.

Click here to obtain the Fox News app

Howell said there was an absolute link, if the allegations remain, between the experiences of the mid-20th century Tuskegee on African-Americans and study puberty tests on children of the 21st century.

“When I read for the first time (study)-I remembered the experiences of Tuskegee on African-Americans (where the American public health service in uniform) gave them medication … to test treatment; horrible events,” he said.

Fox News Digital also contacted the Los Angeles children’s hospital, which was listed as the Affiliation Medical Center for Olson-Kennedy. A number listed for the practice of California of Olson-Kennedy has been disconnected.

She told Times in October 2024 that she then intended to publish the data but blamed delays on funding reductions – an affirmation that the NIH refused, the newspaper reported.